[1]Ê©Ò¦,Ñ»ª*.µÍ¶ÈÁÛ×´ÉÏƤÄÚ²¡±ä»¼Õß¹ÜÀíµÄÑо¿ÏÖ×´[J].Öйú¼Æ»®ÉúÓýºÍ¸¾²ú¿Æ,2018,(5):29-32,48.

µã»÷¸´ÖÆ

µÍ¶ÈÁÛ×´ÉÏƤÄÚ²¡±ä»¼Õß¹ÜÀíµÄÑо¿ÏÖ×´

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

£Û1£ÝLatsuzbaia A, Hebette G, Fischer M, et al. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg £ÛJ£Ý. Diagn Cytopathol, 2017, 45(5): 384-390. £Û2£ÝMassad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors £ÛJ£Ý. J Low Genit Tract Dis, 2013, 17(5 Suppl 1): S1-S27. £Û3£ÝLongatto-Filho A, Levi JE, Martins TR, et al. Critical analyses of the introduction of liquid-based cytology in a public health service of the state of Sao paulo,Brazil£ÛJ£Ý. Acta Cytol, 2015, 59(3): 273-277. £Û4£ÝCiavattini A, Clemente N, Tsiroglou DA, et al. Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be?£ÛJ£Ý. Arch Gynecol Obstet, 2017, 295(4): 997-1003. £Û5£ÝBarron S, Austin RM, LI Zai-bo, et al. Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results £ÛJ£Ý. Am J Clin Pathol, 2015, 143(4): 485-491. £Û6£ÝKashyap V, Hedau S, Bhambhani S. Defining the validity of classical and non-classical cellular changes indicative of low-grade squamous intraepithelial lesion encompassing human papillomavirus infection in relation to human papillomavirus deoxyribonucleic acid testing£ÛJ£Ý. J Cytol, 2011, 28(4): 159-164. £Û7£ÝBigras G, Wilson J, Russell L, et al. Interobserver concordance in the assessment of features used for the diagnosis of cervical atypical squamous cells and squamous intraepithelial lesions (ASC-US, ASC-H, LSIL and HSIL)£ÛJ£Ý. Cytopathology, 2013, 24(1): 44-51. £Û8£ÝSilveira FA, Almeida G, Furtado YL, et al. The association of HPV genotype with the regression, persistence or progression of low-grade squamous intraepithelial lesions£ÛJ£Ý. Exp Mol Pathol, 2015, 99(3): 702-706. £Û9£ÝWentzensen N, Arbyn M, Berkhof J, et al. Eurogin 2016 roadmap: how HPV knowledge is changing screening practice £ÛJ£Ý. International Journal of Cancer, 2017, 140(10): 2192-2200. £Û10£ÝPersson M, Elfstrom KM, Olsson S, et al. Minor cytological abnormalities and up to 7-year risk for subsequent high-grade lesions by HPV type £ÛJ£Ý. PLoS One, 2015, 10(6): e127444. £Û11£ÝIwata T, Hasegawa T, Ochiai KA, et al. Human papillomavirus test for triage of Japanese women with low-grade squamous intraepithelial lesions£ÛJ£Ý. Reproductive Sciences, 2015, 22(12): 1509-1515. £Û12£ÝArbyn M, Roelens J, Simoens C, et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions£ÛJ£Ý. Cochrane Database Syst Rev, 2013,2013 (3): CD008054. £Û13£ÝJakobsson M, Tarkkanen J, Auvinen E, et al. Colposcopy referral rate can be reduced by high-risk human papillomavirus triage in the management of recurrent atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion cytology in Finland £ÛJ£Ý. Int J STD AIDS, 2012, 23(7): 485-489. £Û14£ÝLevi AW, Harigopal M, HUI Pei, et al. Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions£ÛJ£Ý. Cancer Cytopathol, 2011, 119(4): 228-234. £Û15£ÝVeijalainen O, Kares S, Kujala P, et al. Human papillomavirus test with cytology triage in organized screening for cervical cancer£ÛJ£Ý. Acta Obstet Gynecol Scand, 2016, 95(11): 1220-1227. £Û16£ÝS¢irbye SW, Fismen S, Gutteberg TJ, et al. HPV mRNA testing is more specific than HPV DNA testing in triage of women with minor cervical lesions £ÛJ£Ý. PLoS One, 2014, 9(11): e112934. £Û17£ÝWaldstrom M, Ornskov D. Clinical performance of a human papillomavirus messenger RNA test (aptima HPV assay) on residual material from archived 3-year-old preservcyt samples with low-grade squamous intraepithelial lesion £ÛJ£Ý. Arch Pathol Lab Med, 2011, 135(8): 1052-1056. £Û18£ÝAkbayir O, Cilesiz GB, Numanoglu C, et al. Immediate colposcopic evaluation in postmenopausal women with low-grade squamous intraepithelial lesion cytology £ÛJ£Ý. Acta Obstet Gynecol Scand, 2012, 91(9): 1109-1113. £Û19£ÝKyrgiou M, Kalliala I, Mitra A, et al. Immediate referral to colposcopy versus cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature £ÛJ£Ý. International Journal of Cancer, 2017, 140(1): 216-223. £Û20£ÝAjah L, Chigbu C, Onah H, et al. Cytologic surveillance versus immediate colposcopy for women with a cervical smear diagnosis of low-grade squamous intraepithelial lesion in a poor setting in Nigeria £ÛJ£Ý. Onco Targets Ther£¬2014, 2014£¨7£©: 2169-2173. £Û21£ÝCruickshank ME, Cotton SC, Sharp L, et al. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?£ÛJ£Ý. BJOG, 2015, 122(3): 380-386. £Û22£ÝChogovadze N, Jugeli M, Gachechiladze M, et al. Cytologic,colposcopic and histopathologic correlations of LSIL and HSIL in reproductive and menopausal patients with hyperkeratosis£ÛJ£Ý. Georgian Med News, 2013(217): 22-26. £Û23£ÝWANG T, WU Y-m, SONG F, et al. £ÛJ£Ý. Zhonghua Fu Chan Ke Za Zhi, 2012, 47(12): 888-892. £Û24£ÝKaplan KJ, Dainty LA, Dolinsky B, et al. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions diagnosed during pregnancy £ÛJ£Ý. Cancer, 2004, 102(4): 228-232. £Û25£ÝWuntakal R, Castanon A, Sasieni PD. Pregnancy outcomes after treatment for cervical intraepithelial neoplasia in a single NHS hospital £ÛJ£Ý. International Journal of Gynecological Cancer, 2013, 23(4): 710-715.